# Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera

> **NCT03882307** · EARLY_PHASE1 · UNKNOWN · sponsor: **Assiut University** · enrollment: 40 (estimated)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** sofosbuvir and daclatasvir

## Key facts

- **NCT ID:** NCT03882307
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10
- **Primary completion:** 2022-11
- **Final completion:** 2022-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03882307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03882307, "Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03882307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*